Sławomir Budrewićz

Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease

Agata Mulak, Magdalena Koszewicz, Magdalena Panek-Jeziorna et al. · Frontiers in Neuroscience · 2019 · 131 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Andrzej Friedman, Anna Potulska‐Chromik, Pierre Krystkowiak et al. · PubMed · 2007 · 93 citations

Medicine, Neurology, Pain Management +16

Increased muscle belly and tendon stiffness in patients with Parkinson's disease, as measured by myotonometry

Jarosław Marusiak, Anna Jaskólska, Sławomir Budrewićz et al. · Movement Disorders · 2011 · 73 citations

Medicine, Anatomy, Neurology +15

Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients

Jarosław Marusiak, Anna Jaskólska, Magdalena Koszewicz et al. · Clinical Biomechanics · 2012 · 66 citations

Medicine, Neurology, Pharmacotherapy +13

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease

Monika Białecka, Mateusz Kurzawski, Anna Roszmann et al. · Pharmacogenetics and Genomics · 2012 · 66 citations

Life Sciences, Genetics, Neurology +17